187 related articles for article (PubMed ID: 25550243)
1. [Co-occuring mood and substance use disorders].
Adida M; Kaladjian A; Fakra E; Belzeaux R; Azorin JM
Encephale; 2014 Dec; 40 Suppl 3():S8-S13. PubMed ID: 25550243
[TBL] [Abstract][Full Text] [Related]
2. Current status of co-occurring mood and substance use disorders: a new therapeutic target.
Pettinati HM; O'Brien CP; Dundon WD
Am J Psychiatry; 2013 Jan; 170(1):23-30. PubMed ID: 23223834
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Horsfall J; Cleary M; Hunt GE; Walter G
Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
[TBL] [Abstract][Full Text] [Related]
4. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
[TBL] [Abstract][Full Text] [Related]
5. Relationship of comorbid substance and alcohol use disorders to disability among patients in routine psychiatric practice.
Wilk J; West JC; Rae DS; Regier DA
Am J Addict; 2006; 15(2):180-5. PubMed ID: 16595357
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
7. Major depression and comorbid substance use disorders.
Davis L; Uezato A; Newell JM; Frazier E
Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
[TBL] [Abstract][Full Text] [Related]
8. Divalproex sodium to treat concomitant substance abuse and mood disorders.
Hertzman M
J Subst Abuse Treat; 2000 Jun; 18(4):371-2. PubMed ID: 10812311
[TBL] [Abstract][Full Text] [Related]
9. Three-year incidence and predictors of first-onset of DSM-IV mood, anxiety, and substance use disorders in older adults: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
Chou KL; Mackenzie CS; Liang K; Sareen J
J Clin Psychiatry; 2011 Feb; 72(2):144-55. PubMed ID: 21382305
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
Brady KT; Verduin ML
Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
Clark RE; Xie H; Brunette MF
J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
[TBL] [Abstract][Full Text] [Related]
12. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
[TBL] [Abstract][Full Text] [Related]
13. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
[TBL] [Abstract][Full Text] [Related]
14. Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients.
Tseng MM; Chang CH; Liao SC; Chen HC
BMC Psychiatry; 2017 Feb; 17(1):81. PubMed ID: 28241886
[TBL] [Abstract][Full Text] [Related]
15. Management of comorbid bipolar disorder and substance abuse.
Vornik LA; Brown ES
J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people.
Hides L; Carroll S; Catania L; Cotton SM; Baker A; Scaffidi A; Lubman DI
J Affect Disord; 2010 Feb; 121(1-2):169-74. PubMed ID: 19604584
[TBL] [Abstract][Full Text] [Related]
17. The effects of alcohol and drug dependence on the course of depression.
Agosti V; Levin FR
Am J Addict; 2006; 15(1):71-5. PubMed ID: 16449095
[TBL] [Abstract][Full Text] [Related]
18. Treatment of comorbid affective and substance use disorders. Therapeutic potential of anticonvulsants.
Donovan SJ; Nunes EV
Am J Addict; 1998; 7(3):210-20. PubMed ID: 9702289
[TBL] [Abstract][Full Text] [Related]
19. Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse.
Goldberg JF; Garakani A; Ackerman SH
J Clin Psychiatry; 2012 Dec; 73(12):1525-30. PubMed ID: 23290325
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis: Traitement Pharmacologique des Troubles de L'humeur et des Dépendances Comorbides: Une Revue Systématique et une Méta-Analyse.
Stokes PRA; Jokinen T; Amawi S; Qureshi M; Husain MI; Yatham LN; Strang J; Young AH
Can J Psychiatry; 2020 Nov; 65(11):749-769. PubMed ID: 32302221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
